drugset / Trial / NCT02280135
Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
Phase 1
Completed
8 enrolled
Red de Terapia Celular
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · collabHospital Universitario Virgen de la Arrixaca · collabInstituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca · collabPublic Health Service, Murcia · collabSpanish National Health System · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety of intravitreal injection of autologous bone marrow stem cells in patients with retinitis pigmentosa by a prospective, single-center, randomized, parallel, double-blind, phase I placebo-controlled clinical trial.
Timeline
- Start
- 2014-11
- Primary completion
- 2017-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous bone marrow Stem Cell | Cell therapy | 30 cells | Intravitreal |